Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
INO Inovio Pharmaceuticals
- 1.8400
- -0.0050-0.27%
Close Dec 20 16:00 ET
- 1.8487
- +0.0087+0.47%
Post 19:59 ET
66.42MMarket Cap-0.42P/E (TTM)
1.8500High1.7500Low1.45MVolume1.8300Open1.8450Pre Close2.65MTurnover4.27%Turnover RatioLossP/E (Static)36.10MShares14.748052wk High0.90P/B62.34MFloat Cap1.740052wk Low--Dividend TTM33.88MShs Float2352.0000Historical High--Div YieldTTM5.42%Amplitude1.7400Historical Low1.8280Avg Price1Lot Size
About Inovio Pharmaceuticals Company
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Company Profile
SymbolINO
Company NameInovio Pharmaceuticals
Listing DateDec 8, 1998
Founded1983
CEODr. Jacqueline E. Shea
MarketNASDAQ
Employees122
Fiscal Year Ends12-31
Address660 West Germantown Pike,Suite 110
CityPlymouth Meeting
ProvincePennsylvania
CountryUnited States of America
Zip Code19462-1111
Phone1-267-440-4200
Websitehttp://www.inovio.com
Company Executives
- Name
- Position
- Salary
- Dr. Jacqueline E. Shea
- President, Chief Executive Officer and Director
- 2.07M
- Dr. Laurent Humeau, PhD
- Chief Scientific Officer
- 976.66K
- Peter D. Kies
- Chief Financial Officer and Principal Accounting Officer
- 988.73K
- Michael John Sumner
- Chief Medical Officer
- --
- Simon X. Benito
- Chairman of the Board
- 151.19K
- Dr. David B. Weiner, PhD
- Director
- 201.79K
- Dr. Roger D. Dansey, M.D.
- Independent Director
- 108.69K
- Wendy L. Yarno, M.B.A.
- Independent Director
- 123.69K
- Dr. Ann C. Miller, M.D.
- Independent Director
- 126.94K
- Lota S. Zoth, C.P.A.
- Independent Director
- 118.69K
- Jay P. Shepard
- Independent Director
- 119.31K
